-
Review Highlights Microdystrophin Gene Therapy in IGNITE DMD trial
A review study highlights the benefits of adding an extra protein domain – neuronal nitric oxide synthase (nNOS) – to microdystrophin gene therapy. Click here to read more about it.
What do you think about this study and its findings?
Sorry, there were no replies found.
Log in to reply.